Pulse Biosciences, Inc. (PLSE)

USD 17.83

(-7.33%)

Total Liabilities Summary of Pulse Biosciences, Inc.

  • Pulse Biosciences, Inc.'s latest annual total liabilities in 2023 was 16.44 Million USD , down -79.48% from previous year.
  • Pulse Biosciences, Inc.'s latest quarterly total liabilities in 2024 Q3 was 13.91 Million USD , up 3.39% from previous quarter.
  • Pulse Biosciences, Inc. reported annual total liabilities of 80.12 Million USD in 2022, up 331.73% from previous year.
  • Pulse Biosciences, Inc. reported annual total liabilities of 18.55 Million USD in 2021, up 0.87% from previous year.
  • Pulse Biosciences, Inc. reported quarterly total liabilities of 13.45 Million USD for 2024 Q2, up 4.52% from previous quarter.
  • Pulse Biosciences, Inc. reported quarterly total liabilities of 12.87 Million USD for 2024 Q1, down -21.69% from previous quarter.

Annual Total Liabilities Chart of Pulse Biosciences, Inc. (2023 - 2014)

Historical Annual Total Liabilities of Pulse Biosciences, Inc. (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 16.44 Million USD -79.48%
2022 80.12 Million USD 331.73%
2021 18.55 Million USD 0.87%
2020 18.39 Million USD 64.6%
2019 11.17 Million USD 159.59%
2018 4.3 Million USD 12.55%
2017 3.82 Million USD 276.57%
2016 1.01 Million USD 54.0%
2015 659.76 Thousand USD -63.78%
2014 1.82 Million USD 0.0%

Peer Total Liabilities Comparison of Pulse Biosciences, Inc.

Name Total Liabilities Total Liabilities Difference
Akoya Biosciences, Inc. 126.59 Million USD 87.011%
AngioDynamics, Inc. 112.08 Million USD 85.329%
AtriCure, Inc. 147.76 Million USD 88.871%
Avinger, Inc. 19.97 Million USD 17.665%
Azenta, Inc. 351.22 Million USD 95.318%
BioLife Solutions, Inc. 75.05 Million USD 78.09%
The Cooper Companies, Inc. 4.1 Billion USD 99.6%
Daxor Corporation 858.75 Thousand USD -1814.858%
Ekso Bionics Holdings, Inc. 16.31 Million USD -0.809%
Femasys Inc. 9.4 Million USD -74.876%
GlucoTrack, Inc. 1.7 Million USD -862.763%
Harvard Bioscience, Inc. 64.29 Million USD 74.423%
Hologic, Inc. 4.02 Billion USD 99.592%
ICU Medical, Inc. 2.25 Billion USD 99.271%
Intuitive Surgical, Inc. 2.04 Billion USD 99.196%
KORU Medical Systems, Inc. 8.1 Million USD -102.832%
LeMaitre Vascular, Inc. 48.87 Million USD 66.357%
Innovative Eyewear, Inc. 659.93 Thousand USD -2391.757%
Innovative Eyewear, Inc. 659.93 Thousand USD -2391.757%
Masimo Corporation 1.67 Billion USD 99.019%
Microbot Medical Inc. 3.82 Million USD -329.796%
Meihua International Medical Technologies Co., Ltd. 25.07 Million USD 34.427%
Merit Medical Systems, Inc. 1.12 Billion USD 98.536%
Nephros, Inc. 3.5 Million USD -369.426%
NovoCure Limited 783.63 Million USD 97.902%
NEXGEL, Inc. 4.78 Million USD -243.37%
NEXGEL, Inc. 4.78 Million USD -243.37%
Singular Genomics Systems, Inc. 86.46 Million USD 80.981%
OraSure Technologies, Inc. 52.17 Million USD 68.482%
Pro-Dex, Inc. 23.34 Million USD 29.555%
Predictive Oncology Inc. 6.14 Million USD -167.579%
Precision Optics Corporation, Inc. 6.84 Million USD -140.241%
QuidelOrtho Corporation 3.55 Billion USD 99.538%
Repligen Corporation 853.2 Million USD 98.073%
Sanara MedTech Inc. 29.28 Million USD 43.845%
STAAR Surgical Company 102.73 Million USD 83.994%
Sharps Technology, Inc. 3.85 Million USD -326.565%
Utah Medical Products, Inc. 7.14 Million USD -130.147%
DENTSPLY SIRONA Inc. 4.07 Billion USD 99.597%
Jin Medical International Ltd. 8.92 Million USD -84.26%